Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms - Scorecard - MDSpire

Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms

  • By

  • Zhenwei Li

  • Liming Zhao

  • Pengpeng Yan

  • Shangyu Jin

  • Hao Liang

  • Ziqiang Liu

  • Yang Liu

  • Yuxue Sun

  • Tao Gao

  • Chaoyue Li

  • Gaochao Guo

  • July 6, 2026

  • 0 min

Share

Clinical Scorecard: Factors Influencing Collateral Circulation Development Following Revascularization in Moyamoya Disease: Mechanisms and Implications

At a Glance

CategoryDetail
ConditionMoyamoya Disease
Key MechanismsGenetic susceptibility, angiogenic growth factors, cellular components, structural regulators, clinical variables
Target PopulationPatients with moyamoya disease undergoing cerebral revascularization
Care SettingCerebral revascularization surgery

Key Highlights

  • Cerebral revascularization improves cerebral perfusion and may reduce stroke recurrence.
  • Postoperative collateral circulation formation varies significantly among individuals.
  • Factors influencing collateral circulation include genetic variants, angiogenic factors, and surgical modalities.
  • Direct revascularization may lead to better angiographic outcomes and lower stroke risk compared to indirect methods.
  • Poor collateral circulation is associated with higher incidence of recurrent ischemia and hemorrhage.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of moyamoya disease is based on clinical presentation and angiographic findings.

Management

  • Cerebral revascularization is the primary treatment for moyamoya disease.

Monitoring & Follow-up

  • Monitor for recurrent ischemia or hemorrhage post-revascularization.

Risks

  • Risks include hyperperfusion syndrome and variability in collateral circulation formation.

Patient & Prescribing Data

Patients with moyamoya disease undergoing surgical intervention.

Pharmacological treatments have limited effects; surgical options are preferred.

Clinical Best Practices

  • Consider genetic testing for RNF213 variants in patients with moyamoya disease.
  • Evaluate surgical modality based on individual patient risk factors and expected outcomes.
  • Implement a multidisciplinary approach for managing moyamoya disease.

Related Resources & Content

Original Source(s)

Related Content